The chameleon that is Kimberly-Clark Enstra

摘要

Kimberly-Clark Enstra's modifications in the form of TM2 and JS2 are just the beginning of a series of greater changes that will better position the mill to adapt to future tissue markets. I visited Kimberly-Clark South Africa's Enstra mill with the intention of producing a reflective article on how the mill's extension and upgrade (begun in April last year) have impacted the company's local markets and whether they have held fast in the buoyancy of the South African tissue market. Instead, what I found was a mill (and the inspiration for an editorial) that was not built for reflecting but for continually looking forward.